Dexmedetomidine as a part of general anaesthesia for caesarean delivery in patients with pre-eclampsia: A randomised double-blinded trial
European Journal of Anaesthesiology Apr 08, 2018
Eskandr AM, et al. - Whether dexmedetomidine reduces both the stress response and the haemodynamic response to tracheal intubation when administered as a part of general anaesthesia in patients with pre-eclampsia undergoing caesarean delivery, was investigated. Based on dexmedetomidine dosing, three groups were examined: Groups D1and D2 received an infusion of dexmedetomidine 1 μg kg-1 over the 10 min before induction of general anaesthesia, then 0.4 and 0.6 μg kg-1 h-1 dexmedetomidine, respectively. Group C received equivalent volumes of 0.9% saline. Without causing significant adverse neonatal outcome, dexmedetomidine was shown to be related to haemodynamic and hormonal stability when administered in doses 0.4 and 0.6 μg kg-1 h-1.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries